Purpose Prostate specific antigen has decreased performance characteristics for the
detection of prostate cancer in African-American men. We evaluated urinary PCA3 and …

Background Prostate-specific antigen (PSA) is a marker of prostate cancer (PCa), although
its efficacy as a diagnostic marker remains controversial. A high false-positive rate leads to …

Objectives Recent innovations in prostate cancer diagnosis include new biomarkers and
more accurate biopsy methods. This study assesses the evidence base on cost …

This work is a continuation of our research into the development of simple, reliable, and cost-
effective methods for the early diagnosis of prostate cancer (PCa). The proposed method is …

In recent years, rapid advancement in gene/protein analysis technology has resulted in
target molecule identification that may be useful in cancer treatment. Therefore,“Clinical …

The main advantage of urinary biomarkers is their noninvasive character and the ability to
detect multifocal prostate cancer (CaP). We have previously implemented a quadruplex …

Background: Magnetic Resonance Imaging (MRI) of the prostate is a more accurate, non-
invasive test for prostate cancer. Aim: To understand the acceptability of prostate MRI for …

Prostate cancer (PCa) is the second most prevalent cancer in men. In 2020, approximately
1,414,259 new cases were reported that accounted for 3, 75,324 deaths (Sung et al. in CA …

Background Standard biopsy for prostate cancer diagnosis is an unpleasant and sometimes
painful procedure with a detection rate as low as around 50%. Consequently, an accurate …

The most common prostate cancer (PCa) diagnostics, which are based on detection of
prostate-specific antigens (PSA) in blood, have specificity limitations often resulting in both …